IFNG and acute myeloid leukemia: The outcome demonstrated that this CD38-targeting T-cell engager could stimulate T cells to release IFN-γ and transform surrounding CD38neg cells into CD38pos cells when interacting with CD38pos AML cells, thereby efficiently eliminating AML.